Company / Capital Returned to Shareholders
CVS Health Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$3.4B
FY2025
5-year range
$2.6B / $6.4B
FY2021-FY2025
Trend
-46.9%
vs FY2024
Sector context
#9 of 108
Health Care
What the data says
Among 108 Health Care companies, CVS Health is in the top 8% for capital returned to shareholders. Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $2.0B in FY2020 to $6.4B in FY2017.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of +10.8%. Top quartile in the Health Care sector.
Improved from $2.6B to $3.4B over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -19.1%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
+343.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +10.8%, indicating consistent growth.
- In FY2025, capital returned to shareholders decreased 46.9% year-over-year.
- Ranks #9 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | -46.9% |
| FY2024 | $6.4B | +143.7% |
| FY2023 | $2.6B | -59.0% |
| FY2022 | $6.4B | +146.1% |
| FY2021 | $2.6B | +27.7% |
| FY2020 | $2.0B | -21.7% |
| FY2019 | $2.6B | +27.7% |
| FY2018 | $2.0B | -68.2% |
| FY2017 | $6.4B | +1.7% |
| FY2016 | $6.3B | -4.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026